Dental and Medical Problems

Dent Med Probl
Impact Factor (IF 2023) – 2.7
Journal Citation Indicator (JCI 2023) - 1.06
Scopus CiteScore (2023) – 4.0 (CiteScore Tracker – 4.9)
Index Copernicus (ICV 2023) – 181.00
MNiSW – 70 pts
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – bimonthly


 

Download original text (EN)

Dental and Medical Problems

Ahead of print

doi: 10.17219/dmp/201941

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Grzech-Leśniak Z, Pyrkosz J, Szwach J, et al. In vitro evaluation of the effect of Er:YAG laser with a fractional PS04 handpiece on microbial biofilm survival [published online as ahead of print on March 24, 2025]. Dent Med Probl. doi:10.17219/dmp/201941

In vitro evaluation of the effect of Er:YAG laser with a fractional PS04 handpiece on microbial biofilm survival

Zuzanna Grzech-Leśniak1,A,B,C,D, Jakub Pyrkosz2,B, Jagoda Szwach2,B, Martyna Lelonkiewicz2,B, Magdalena Pajączkowska3,A,B,C, Joanna Nowicka3,A,B,C, Jacek Matys4,C,D,E,F, Kinga Grzech-Leśniak4,A,B,C,D,E,F

1 Faculty of Medicine and Dentistry, Wroclaw Medical University, Poland

2 Faculty of Medicine, Wroclaw Medical University, Poland

3 Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Poland

4 Laser Dentistry Laboratory, Department of Dental Surgery, Wroclaw Medical University, Poland

Graphical abstract


Graphical abstracts

Highlights


  • The Er:YAG laser with the PS04 fractional handpiece significantly reduced Candida albicans, Candida glabrata and Streptococcus mutans biofilms, with higher fluence showing superior efficacy.
  • Higher fluence was more effective against C. albicans and S. mutans, while lower fluence showed stronger effects on C. glabrata over 24 h.
  • Mixed-species biofilms responded differently, with C. glabrata and S. mutans showing greater reductions under higher fluence, supporting tailored laser protocols.
  • Low-fluence Er:YAG laser, used in facial aesthetic procedures and snoring treatments, demonstrates antifungal and antibacterial potential in dentistry.

Abstract

Background. The oral microbiota consists of a diverse range of microorganisms, with Streptococcus spp. and Candida spp. frequently coexisting in oral infections.

Objectives. The aim of the study was to investigate the impact of Er:YAG (erbium-doped yttrium aluminum garnet) laser therapy, utilizing the PS04 fractional beam, on the in vitro growth and biofilm formation of clinical strains of Candida albicans, Candida glabrata and Streptococcus mutans.

Material and methods. Single- and dual-species planktonic cultures and biofilms were exposed to an Er:YAG laser using a fractional PS04 handpiece. The effects of the laser were evaluated immediately after irradiation and 24 h post-irradiation by measuring colony-forming units per milliliter (CFU/mL). Biofilm biomass (single- and dual-species) was quantified using the crystal violet staining method. The study tested 2 sets of laser parameters: group 1 (T1): 1.5 W, 10 Hz, 30 s, 0.4 J/cm2, irradiance: 3.9 W/cm2; and group 2 (T2): 6.15 W, 10 Hz, 30 s, 1.6 J/cm2, irradiance: 16 W/cm2. Non-irradiated samples served as controls. The parameters were selected based on their frequent clinical use for snoring treatment and facial rejuvenation.

Results. Candida albicans exhibited a significantly greater reduction under T2 settings in comparison to T1 (85.3 ±1.2% vs. 43.9 ±4.5%, respectively; p = 0.006) within single-species biofilms. For C. glabrata, a significant reduction was observed under T1 parameters (69.8 ±14.9%). Furthermore, S. mutans demonstrated a significantly higher reduction at T2 settings (97.1 ±0.6%) compared to T1 settings (81.1 ±19.6%), with statistically significant differences noted between S. mutans and both C. albicans and C. glabrata under T1, as well as between S. mutans and C. glabrata under T2. In dual-species biofilms, T2 fluence led to greater reductions in C. glabrata, S. mutans and C. albicans in mixed cultures (p < 0.05).

Conclusions. The Er:YAG laser, when used in conjunction with the PS04 handpiece, demonstrated a substantial reduction in the biofilms of C. albicans and C. glabrata. Higher fluence maintained reductions over a 24-h period, particularly in the case of C. glabrata and S. mutans. This study highlights the antifungal potential of low-fluence laser settings that are commonly used in facial aesthetic procedures and snoring treatment.

Keywords: Candida albicans, candidiasis, oral biofilm, erbium laser, Streptococcus mutans

Introduction

The health of the oral cavity is closely interconnected with systemic health.1, 2, 3 Rather than being merely susceptible to microbial colonization, the oral cavity naturally harbors a diverse and dynamic microbial community. This is due to its continuous exposure to the external environment through food, air and other factors, which contribute to the establishment and maintenance of a complex ecosystem of bacteria, fungi and other microorganisms. These microbes can disrupt oral homeostasis, leading to dental caries, periapical infections and candidiasis. In some cases, microbial dysbiosis may contribute to systemic diseases, including cardiovascular disorders, pneumonia and stroke.4 Among the primary pathogens involved, Streptococcus mutans is a key etiological agent in dental caries and a contributor to systemic conditions such as infective endocarditis.5 Additionally, fungal infections, primarily caused by Candida albicans, can disrupt the balance of oral microbiota and pose significant challenges due to their opportunistic nature and resistance.6

A critical factor in the development of oral candidiasis is its nature as a multi-species infection, as opposed to being caused by a single fungal species. While C. albicans is the predominant species responsible for infections, it exists alongside diverse strains and other Candida species, which further complicates infection management. In severe cases, Candida spp. may invade the bloodstream, leading to systemic, life-threatening conditions such as candidemia.6 Conventional treatment for oral candidiasis includes antifungal agents such as nystatin, amphotericin B, or systemic therapies like ketoconazole, fluconazole and 5-fluorocytosine. However, systemic anti­fungal treatments frequently cause adverse effects, including gastrointestinal disturbances, nephrotoxicity and hepatotoxicity, highlighting the need for innovative strategies.7 Emerging alternatives, such as probiotics, show promise in preventing oral candidiasis and alleviating symptoms, yet they remain less effective for treating established infections.8, 9, 10, 11, 12

Laser therapy has emerged as a promising and increasingly popular approach in disease management over the years.13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 The antimicrobial action of the laser is particularly noteworthy and widely emphasized.26, 27, 28, 29, 30 Among var­ious types of lasers, the Er:YAG (erbium-doped yttrium aluminum garnet) laser has found wide application in multiple fields of dentistry.31, 32, 33, 34, 35, 36 Studies have demonstrated the effectiveness of the Er:YAG laser in managing microbial biofilm during endodontic treatment37, 38, 39, 40, 41 and reducing biofilm on dental implants affected by peri-implantitis.42, 43 Additionally, Er:YAG laser bleaching has been shown to reduce biofilm formation on enamel surfaces in compari­son to conventional bleaching methods without laser application.44 These findings, along with others, highlight the beneficial effects of Er:YAG laser therapy in inhibiting or reducing biofilm formation in the oral cavity.45, 46, 47, 48 Beyond its efficacy in destroying bacterial biofilms, the Er:YAG laser has also shown potential in reducing Candida biofilm formation, further expanding its potential applications in dental and oral health management.22, 49, 50

The present study aims to evaluate the effects of the Er:YAG laser on planktonic single-species, dual-species, and biofilm composed of C. albicans, Candida glabrata and S. mutans strains. Additionally, it explores innovative approaches to eradicate these pathogens using low-fluence laser parameters, specifically designed for the clinical management of snoring and frequently employed in facial aesthetic procedures.

Material and methods

The research was carried out on clinical strains of C. albicans, C. glabrata and S. mutans at the Department of Microbiology, Wroclaw Medical University, Poland, under the approval of the Institutional Research Ethics Committee (approval No. KB-429/2024). A power meter was utilized, and the output was calibrated prior to the commencement of the study.

Culture condition

Clinical cultures of C. albicans, C. glabrata and S. mutans were obtained from patients with candidiasis and caries lesions and stored at −80°C in Trypticasein Soy Broth (BioMaxima, Lublin, Poland). The strains were frozen in replicates and multiplied before experiments (S. mutans on Brain Heart Infusion (BHI) LAB-AGAR; Candida spp. on Sabouraud Dextrose LAB-AGAR (BioMaxima)).

Two types of samples were prepared for experimentation:

• planktonic solutions: suspensions of microorganisms (0.5 McFarland standard) were combined with BHI broth (BioMaxima) containing 5% sucrose, forming single-species (C. albicans, C. glabrata, S. mutans) or dual-species combinations (C. albicans + S. mutans; C. glabrata + S. mutans; C. albicans + C. glabrata). The treatments were conducted in dark Eppendorf tubes (SARSTEDT AG & Co. KG, Nümbrecht, Germany);

biofilm: single- and dual-species biofilms were formed on 96-well polystyrene plates (SPL Life Sciences Co., Ltd., Pocheon, Korea). For single-species biofilms, 100 µL of microbial suspensions (0.5 McFarland standard) and 150 µL of BHI broth were added per well. For dual-species biofilms, 100 µL of each microorganism suspension and 50 µL of BHI broth were used, totaling 250 µL per well. The plates were incubated at 37°C for 24 h under aerobic or CO2-enhanced conditions (S. mutans).

Laser irradiation

The experiment used an Er:YAG laser (LightWalker AT-S; Fotona, Ljubljana, Slovenia) equipped with a fractional PS04 handpiece (Fotona). The laser was operated in a non-contact mode with a 600-μs long pulse duration, maintaining a 10-mm distance from the surface of strain suspension in the Eppendorf tube (plankton) or 96-well polystyrene plates (biofilm) (Figure 1). The delivery system employed an articulated arm. In both test groups, the same fractional handpiece was used, with 2 variations in parameters. One set was designed for facial rejuvenation, while the other was specifically configured for the clinical treatment of snoring. The control group was biofilm without laser irradiation. The parameters used in the study are outlined in Table 1.

Microorganism quantification

Planktonic cell suspensions

Single- and dual-species planktonic suspensions were exposed to laser light in dark Eppendorf tubes. For the assessment of immediate effects, 100 µL of suspension was serially diluted, and 100 µL from each dilution was plated on BHI agar. The plates were then incubated at 37°C for 24 h under aerobic (yeast) or elevated CO2 conditions (S. mutans and dual-species). Colonies were counted to calculate colony forming units per milliliter (CFU/mL). Control suspensions were subjected to the same protocol without laser exposure.

To assess the effects 24 h post-irradiation, the suspensions underwent incubation at 37°C under aerobic or CO2 conditions, followed by serial dilution, plating and colony counting. Controls were prepared in a similar manner, without irradiation.

Effect of laser on single- and dual-species biofilm (quantification of CFU/mL)

Biofilm samples cultivated for 24 h were rinsed with 0.9% NaCl to remove any unattached cells. Thereafter, the samples were irradiated with a laser, scraped using sterile swabs and shaken in a 0.5% saponin solution. Subsequently, they were processed via serial dilution and plating. The plates were incubated at 37°C for 24 h under aerobic or CO2 conditions, after which CFU/mL values were calculated.

Effect of laser on single- and dual-species biofilm (crystal violet method)

Biofilm samples cultivated for 24 h were rinsed with 0.9% NaCl to remove any unattached cells. Subsequently, the samples were exposed to laser irradiation. Then, they were fixed by drying for 45 min at room temperature. After the drying period, 250 µL of 0.1% crystal violet solu­tion (Chempur®, Piekary Śląskie, Poland) was added to the wells, and the plate was left for 20 min at room temperature. Subsequently, the violet was removed and the wells were washed 3 times in distilled water. Thereafter, they were left to dry for 20 min at room temperature. After adding 200 µL of 95% ethanol (Honeywell, Charlotte, USA), the absorbance was measured at a wavelength (λ) of 540 nm (Asys UVM 340; Biochrom Ltd., Holliston, USA). The control group consisted of a microbial biofilm that had not been exposed to the laser.

Statistical analysis

The Kolmogorov–Smirnov test was performed at a 95% confidence interval (CI) to evaluate the normality of data distribution. Differences in microorganism reduction following laser irradiation were analyzed using multivariate analysis of variance (MANOVA). Post-hoc adjustments were implemented using the Holm–Bonferroni method to control for multiple comparisons. All statistical analyses were carried out using Statistica software, v. 12 (StatSoft, Kraków, Poland), with a significance level set at p < 0.05.

Results

Reduction of microorganisms in single-species planktonic cultures

The results demonstrate that laser application significantly reduced microorganism cell counts in single-species planktonic cultures in comparison to the control group. The most substantial reductions were observed for S. mutans and C. albicans when the PS04 handpiece was used directly after irradiation (DAI) at higher fluence settings (T2). Statistically significant differences were identified between the DAI and 24 h after irradiation (24AI) time points for S. mutans (80.0 ±1.3% vs. 0.0 ±0.0%; p < 0.001) and C. albicans (74.0 ±8.3% vs. 31.7 ±10.2%; p = 0.045) under T2 settings. Furthermore, higher laser fluence (T2) resulted in a significantly greater reduction of C. albicans immediately after irradia­tion (p < 0.05). Conversely, lower fluence (T1) achieved superior reductions for C. glabrata and S. mutans 24 h post-irradiation compared to T2 (p < 0.05) (Table 2).

Reduction of microorganisms in single-species biofilm cultures

The study assessed the reduction of microbial cell counts in biofilm cultures of C. albicans, C. glabrata and S. mutans, directly after irradiation, with an Er:YAG laser used in conjunction with the PS04 handpiece. The results showed that for C. albicans, T2 parameters achieved a significantly higher reduction compared to T1 (85.3 ±1.2% vs. 43.9 ±4.5%, respectively; p = 0.006), thereby demonstrating enhanced efficacy. In contrast, C. glabrata exhibited a substantial reduction under T1 settings, but no reduction at higher fluence (69.8 ±14.9% vs. 0.0 ±0.0%, respectively; p = 0.022). Streptococcus mutans demonstrated consistently high reductions in both configurations (81.1 ±19.6% for T1 and 97.1 ±0.6% for T2; > 0.05). Inter-group comparisons indicated significant variation among the species (p < 0.05), with S. mutans showing the highest overall reduction (T2: 97.1 ±0.6%; T1: 81.1 ±19.6%), which was significantly greater compared to C. albicans and C. glabrata under T1 settings, as well as C. glabrata under T2 settings (p < 0.05) (Table 3).

Reduction of microorganisms in dual-species planktonic cultures

The results of microbial cell counts in dual-species planktonic cultures (C. albicans + C. glabrata, C. albicans + S. mutans, and C. glabrata + S. mutans) following Er:YAG laser application using the PS04 hand­piece revealed significant variability in reduction rates depending on the species combination, laser settings (T1 vs. T2) and timing (DAI vs. 24AI). Candida albicans in the C. albicans + S. mutans mixture showed a signif­icantly higher reduction with T2 settings at 24AI com­pared to DAI (83.7 ±5.9% vs. 7.4 ±0.1%, respectively; p = 0.003). A similar trend was observed for S. mutans in the same mixture, which exhibited significant reduc­tions with T1 settings at 24AI compared to DAI (24.9 ±2.3% vs. 0.0 ±0.0%, respectively; p = 0.004). For the C. glabrata + S. mutans biofilm, reductions were signif­icantly greater at 24AI compared to DAI under certain conditions (T2: 39.2 ±10.4% at 24AI vs. 0.0 ±0.0% at DAI; p = 0.033). Moreover, a greater microbial reduction for S. mutans in the C. albicans + S. mutans mixture was observed with T2 settings immediately after laser application, while the opposite was observed 24 h post-irradiation (p < 0.05). Additionally, for the C. glabrata + S. mutans mixture, a greater reduction in S. mutans was found with T1 settings immediately after laser application compared to results measured 24 h after laser irradiation (p < 0.05) (Table 4).

Reduction of microorganisms in dual-species biofilm cultures

Higher laser fluence (T2) exhibited a greater reduction in C. glabrata (C. albicans + C. glabrata and C. glabrata + S. mutans mixtures), S. mutans (C. albicans + S. mutans and C. glabrata + S. mutans mixtures) and C. albicans (C. albicans + C. glabrata mixture) (p < 0.05). No significant increase in reduction was observed for C. albicans in the C. albicans + S. mutans mixture when comparing the 2 irradiation configurations (Table 5).

Laser-induced biomass reduction in single- and dual-species biofilms evaluated using the crystal violet method

The application of the Er:YAG laser in conjunction with the PS04 handpiece demonstrated varying effectiveness in reducing biofilm biomass, depending on laser power settings. For C. albicans, an increase in power from T1 (13.6 ±2.5%) to T2 (14.9 ±1.4%) did not result in a significant reduction (p = 0.571). In contrast, C. glabrata exhibited a substantial decrease in biomass from T1 to T2 (13.4 ±3.1% vs. 51.15 ±8.0%, respectively; p = 0.023), suggesting a greater sensitivity to elevated laser power. Streptococcus mutans showed an increase in biomass reduction from T1 (13.8 ±5.3%) to T2 (24.05 ±1.3%), but this change was not statistically significant (p = 0.099). Multivariate analysis of variance confirmed significant differences between the species (p = 0.009), with the most notable differences observed between C. glabrata and C. albicans (p < 0.009) and between C. glabrata and S. mutans (p < 0.022) (Table 6).

The application of the Er:YAG laser (PS04 handpiece) resulted in varied biomass reduction across different dual-species biofilms, depending on microbial composition and laser power settings. In the C. albicans + S. mutans biofilm, a substantial biomass reduction was observed, decreasing from T1 to T2 (18.8 ±0.8% vs. 11.4 ±0.9%, respectively; p = 0.014), indicating lower efficacy at higher power. Conversely, the C. glabrata + S. mutans biofilm reduction demonstrated a significant decrease from T1 to T2 (23.2 ±5.4% vs. 0.3 ±0.2%, respectively; p = 0.027), suggesting that lower laser power was highly effective against this combination. Moreover, a reduction in biomass was observed for the C. albicans + C. glabrata biofilm when comparing the T1 and T2 settings (31.0 ±13.2% vs. 49.4 ±14.7%, respectively; p = 0.318), imply­ing greater laser efficiency under high-energy conditions (Table 7).

Discussion

The present study is an in-depth examination of the impact of the Er:YAG laser on single-species and dual-species planktonic and biofilm cultures formed by C. albicans, C. glabrata and S. mutans. Additionally, it investigates novel methods for eliminating these pathogens by utilizing low laser parameter settings tailored for the clinical management of facial rejuvenation and snoring. The findings of the current study highlight the potential of the Er:YAG laser with a fractional handpiece as an effective tool for reducing microbial populations in both planktonic and biofilm cultures of C. albicans, C. glabrata and S. mutans. The observed reductions were dependent on laser settings (T1: 0.4 J/cm² vs. T2: 1.6 J/cm²) and microbial species, suggesting that the efficacy of laser treat­ment can be optimized through the precise customization of parameters to the specific clinical context. Notably, the higher fluence settings (T2) demonstrated superior efficacy in disrupting C. albicans and S. mutans in single-species and dual-species planktonic cultures immediately after irradiation, while the lower fluence settings (T1) were more effective for C. glabrata in single-species planktonic cultures 24 h after irradiation. These results align with earlier studies that emphasize the versatility and efficacy of laser-based approaches in microbial management, particularly in addressing challenges related to biofilm-associated infections in the field of dentistry.23, 48, 51

With respect to the results obtained for planktonic cul­tures, the application of the Er:YAG laser in conjunction with the PS04 handpiece demonstrated significant reduc­tions in microbial cell counts, particularly for S. mutans and C. albicans. The most notable reductions were observed under T2 settings, with a 80.0% and 74.0% decrease, respectively, immediately after irradiation. These outcomes are consistent with earlier studies, which also found laser treatment to be effective in reducing the growth of these species, suggesting that the intensity of the laser has a significant impact on microbial survival.52, 53, 54 While S. mutans showed no detectable recov­ery at 24 h post-irradiation, C. albicans exhibited partial resurgence, with a reduction of 31.7%. These findings support earlier research indicating that laser efficacy diminishes over time, particularly for fungal organisms like C. albicans, which may require repeated interventions for long-term control.54 Interestingly, while higher fluence (T2) was more effective against C. albicans immediately after irradiation, lower fluence (T1) yielded better results for C. glabrata and S. mutans at 24AI. These results under­score the importance of optimizing laser parameters for different microorganisms, highlighting that microbial responses to laser treatments can vary significantly depending on the organism type and laser fluence.23, 48, 51

In biofilm cultures, the Er:YAG laser, operated with the PS04 handpiece, demonstrated species-specific efficacy in reducing microbial cell counts. This finding is consistent with the existing literature on biofilm manage­ment. For single-species biofilms, S. mutans exhibited the highest reduction rates, with T2 settings achieving nearly complete eradication (97.1 ±0.6%). This result aligns with the findings reported in the study by Grzech-Leśniak et al., which emphasized the susceptibility of S. mutans biofilm to treatments targeting the biofilm matrix using the Nd:YAG (neodymium-doped yttrium aluminum garnet) laser.23 A comparable response was observed for C. albicans, which exhibited a significant reduction under T2 parameters (85.3 ±1.2%), reflecting its vulnerability to interventions that disrupt extracellular polymeric sub­stances (EPS), as discussed by Salehi et al., who highlighted the challenges of disrupting resilient polymicrobial biofilms.55 In dual-species biofilms, T2 fluence generally achieved greater reductions, particularly for C. glabrata and S. mutans in mixed cultures, as well as for C. albicans in combination with C. glabrata. These findings support evidence presented by Salehi et al., which underscored the significance of tailored approaches to address the synergistic interactions between microbial species within biofilms.55 However, no significant improvement with T2 over T1 settings was observed for C. albicans in combination with S. mutans, suggesting that interspecies interactions might alter biofilm susceptibility. These findings emphasize the potential of the Er:YAG laser in the manage­ment of biofilms and highlight the importance of understanding microbial dynamics to optimize treatment protocols.48, 51, 56

This study builds upon our previous findings, in which the antimicrobial impact of the Nd:YAG laser on C. albicans and S. mutans was explored using both CFU quantification and Janus green staining.22 The use of Janus green staining allowed for a detailed assessment of meta­bolic activity and biofilm viability, providing insights beyond the microbial counts achieved through CFU analysis. This method addressed structural and metabolic biofilm responses, which are critical for understanding the under­lying mechanisms of laser-induced microbial reduction. In the current study, CFU quantification was used to eval­uate the antimicrobial efficacy of the Er:YAG laser. While this method effectively quantifies microbial reduction, it lacks the ability to visualize biofilm structure and viability. Additionally, the study utilized the Nd:YAG laser for photo­biomodulation (PBM) applications,22, 23 targeting deeper tissue interactions. In contrast, the present study explores the surface-level effects of the Er:YAG laser using the fractional PS04 handpiece. The utilization of distinct laser systems and their intended applications highlights the adaptability of these technologies for specific clinical scenarios. While the Nd:YAG laser is effective in manag­ing deeper biofilm in periodontal pockets,14, 21, 24, 26, 49 the Er:YAG laser14, 18, 31, 32, 33, 34, 35, 36, 38, 39, 40, 41, 42, 45, 46, 47, 48, 50, 51, 52, 53 has shown promise in disrupting surface biofilm and enhancing aesthetic or surface-level treatments.57, 58, 59, 60, 61 Overall, integrating advanced visualization techniques, clinically relevant substrates and combined laser systems will provide a more comprehensive understanding of biofilm responses to laser treatment and enhance the translational value of these findings for dental and medical applications.

Limitations

Despite the promising findings of this study, it is imperative to acknowledge its limitations. First, the study was conducted in vitro, which may not fully replicate the complex conditions present in vivo, where additional factors such as host immune responses, saliva and tissue interactions could influence the effectiveness of Er:YAG laser treatments on biofilm. The crystal violet staining method, a widely utilized technique for biofilm biomass quantification due to its simplicity and cost-effectiveness, is not without its limitations, which may affect its reliability. A significant drawback is its inability to differentiate between live and dead cells, as it quantifies total biomass without providing insights into cell viability or metabolic activity. This limitation may lead to an incomplete assessment of the functional state of biofilms. A study by Fernandes et al. emphasizes the importance of multiparametric approaches for more comprehensive evaluations.62 Complementary methods such as live/dead staining, metabolic assays, or confocal microscopy could enhance reliability and address potential biases, including material–biofilm interactions. Future studies should consider these approaches to strengthen findings. Additionally, the study’s focus on only 3 species, C. albicans, C. glabrata and S. mutans, limits the generalizability of the results to other pathogens commonly involved in oral infections. Furthermore, although the study demonstrated significant reductions in microbial populations, the long-term efficacy of the laser treatment was not assessed beyond the 24-hour post-irradiation time point. In clinical settings, the potential for biofilm regrowth necessitates the considera­tion of repeated treatments or combination therapies. The absence of a comprehensive analysis on the potential tis­sue damage or adverse effects of laser application also rep­resents a limitation, as these factors are crucial in clinical applications. These limitations indicate that while Er:YAG lasers demonstrate potential for biofilm disruption, further research, particularly clinical studies, is needed to fully assess their effectiveness in diverse oral environments.

Conclusions

The present study aimed to evaluate the effects of the Er:YAG laser on biofilms composed of C. albicans, C. glabrata and S. mutans strains, with a particular focus on its antifungal and antibacterial properties. However, the findings are limited by the in vitro nature of the study, which does not fully replicate the physiological conditions of the oral environment. Consequently, the outcomes may not directly translate to clinical dentistry. The results suggest that the efficacy of laser treatment is influenced by several factors, including the fluence settings (0.4 J/cm2 and 1.6 J/cm2), microbial species and the time elapsed post-irradiation. Generally, the antifungal effects were evident in the reduction of fungal strains (C. albicans and C. glabrata) immediately after irradiation, with higher fluence settings showing greater efficacy. In contrast, the antibiofilm effect was characterized by sustained microbial reduction over a 24-hour period, particularly at lower fluence settings, with notable effectiveness against C. glabrata and S. mutans in single-species planktonic cultures. Future research should focus on in vivo studies to assess the laser’s effectiveness under real-world conditions, including the complex interplay of oral microbiota, tissue responses and environmental factors.

Ethics approval and consent to participate

The study was approved by the Institutional Research Ethics Committee of Wroclaw Medical University, Poland (approval No. KB-429/2024).

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Use of AI and AI-assisted technologies

ChatGPT 4.0 (OpenAI) was used to verify grammar and make minor adjustments for clarity and accuracy.

Tables


Table 1. Study groups and laser parameters used during the experiment

Laser

Handpiece

Study group 1 (T1)

Study group 2 (T2)

Control group

Er:YAG

PS04
(fractional)

1.5 W, 10 Hz, 30 s, fluency: 0.4 J/cm2, LP (600 µs), no tip, 7-mm spot, power density (irradiance): 3.9 W/cm2

6.15 W, 10 Hz, 30 s, fluency: 1.6 J/cm2; LP (600 µs), no tip, 7-mm spot, power density (irradiance): 16 W/cm2

no laser irradiation

clinical use: facial rejuvenation

clinical use: snoring treatment

Er:YAG – erbium-doped yttrium aluminum garnet; LP – long pulse.
Table 2. Reduction in microbial cell count after laser treatment in single-species planktonic cultures compared to the control group (non-irradiated samples)

Microorganism

Handpiece

Time

Reduction at T1
[%CFU/mL]
M ±SD

Reduction at T2
[%CFU/mL]
M ±SD

p-value
(T1 vs. T2)

Candida albicans

PS04

DAI

46.5 ±3.0

74.0 ±8.3

0.048*

24AI

39.2 ±27.4

31.7 ±10.2

0.752

p-value
(DAI vs. 24AI)

0.744

0.045*

Candida glabrata

DAI

70.6 ±13.8

65.5 ±5.8

0.680

24AI

78.8 ±0.6

69.6 ±2.1

0.028*

p-value
(DAI vs. 24AI)

0.489

0.447

Streptococcus mutans

DAI

63.3 ±21.7

80.0 ±1.3

0.391

24AI

39.1 ±7.8

0.0 ±0.0

0.019*

p-value
(DAI vs. 24AI)

0.277

<0.001*

* statistically significant (p < 0.05, MANOVA); DAI – directly after irradiation; 24AI – 24 h after irradiation; T1 – lower fluence laser settings; T2 – higher fluence laser settings; CFU – colony-forming units; M – mean; SD – standard deviation.
Table 3. Reduction in microbial cell count directly after laser treatment in single-species biofilm cultures compared to the control group (non-irradiated samples)

Microorganism

Handpiece

Reduction at T1
[%CFU/mL]
M ±SD

Reduction at T2
[%CFU/mL]
M ±SD

p-value
(T1 vs. T2)

Candida albicans

PS04

43.9 ±4.5

85.3 ±1.2

0.006*

Candida glabrata

69.8 ±14.9

0.0 ±0.0

0.022*

Streptococcus mutans

81.1 ±19.6

97.1 ±0.6

0.366

* statistically significant (p < 0.05, MANOVA).
Table 4. Reduction in microbial cell count after laser treatment in dual-species planktonic cultures

Microorganism

Mixture

Handpiece

Time

Reduction at T1
[%CFU/mL]
M ±SD

Reduction at T2
[%CFU/mL]
M ±SD

p-value
(T1 vs. T2)

Candida albicans (Ca)

Ca+Cg

PS04

DAI

6.7 ±9.4

40.0 ±9.5

0.072

24AI

42.5 ±14.4

45.9 ±2.1

0.769

p-value
(DAI vs. 24AI)

0.098

0.481

Ca+Sm

DAI

56.9 ±25.5

7.4 ±0.1

0.111

24AI

67.0 ±3.6

83.7 ±5.9

0.069

p-value
(DAI vs. 24AI)

0.667

0.003*

Candida glabrata (Cg)

Ca+Cg

PS04

DAI

24.1 ±3.5

36.9 ±21.6

0.496

24AI

9.5 ±10.1

7.9 ±11.1

0.894

p-value
(DAI vs. 24AI)

0.193

0.233

Ca+Sm

DAI

39.8 ±13.7

26.3 ±2.0

0.302

24AI

40.4 ±33.4

4.1 ±5.8

0.270

p-value
(DAI vs. 24AI)

0.985

0.429

Streptococcus mutans (Sm)

Ca+Cg

PS04

DAI

0.0 ±0.0

62.7 ±12.8

0.020*

24AI

24.9 ±2.3

1.4 ±1.9

0.008*

p-value
(DAI vs. 24AI)

0.004*

0.022*

Ca+Sm

DAI

60.0 ±7.1

0.0 ±0.0

0.007*

24AI

43.8 ±12.8

39.2 ±10.4

0.731

p-value
(DAI vs. 24AI)

0.257

0.033*

* statistically significant (p < 0.05, MANOVA).
Table 5. Reduction in microbial cell count directly after laser treatment in dual-species biofilm cultures

Microorganism

Mixture

Handpiece

Reduction at T1
[%CFU/mL]
M ±SD

Reduction at T2
[%CFU/mL]
M ±SD

p-value
(T1 vs. T2)

Candida albicans (Ca)

Ca+Cg

PS04

98.1 ±0.6

100.0 ±0.0

0.042*

Ca+Sm

51.5 ±33.3

98.4 ±0.7

0.184

Candida glabrata (Cg)

Ca+Cg

93.8 ±0.2

99.9 ±0.1

0.001*

Cg+Sm

61.4 ±2.3

99.2 ±1.1

0.002*

Streptococcus mutans (Sm)

Ca+Sm

61.0 ±10.9

98.6 ±1.1

0.040*

Cg+Sm

46.9 ±7.8

100.0 ±0.0

0.011*

* statistically significant (p < 0.05, MANOVA).
Table 6. Reduction in single-species biofilm biomass after the application of the Er:YAG (erbium-doped yttrium aluminum garnet) laser in conjunction with the crystal violet method

Handpiece

Microorganism

Reduction in biomass
[%]

p-value

T1
M ±SD

T2
M ±SD

PS04

Candida albicans (Ca)

13.6 ±2.5

14.9 ±1.4

0.571

Candida glabrata (Cg)

13.4 ±3.1

51.2 ±8.0

0.023*

Streptococcus mutans (Sm)

13.8 ±5.3

24.1 ±1.3

0.099

p-value

0.996a

0.009a
Cg vs. Ca: p < 0.009b
Cg vs. Sm: p < 0.022b

* statistically significant (p < 0.05, MANOVA); a MANOVA; b Tukey’s post hoc test.
Table 7. Reduction in dual-species biofilm biomass after the application of the Er:YAG (erbium-doped yttrium aluminum garnet) laser in conjunction with the crystal violet method

Mixture

Reduction in biomass
[%]

p-value
(T1 vs. T2)

T1
M ±SD

T2
M ±SD

Ca+Sm

18.8 ±0.8

11.4 ±0.9

0.014*

Cg+Sm

23.2 ±5.4

0.3 ±0.2

0.027*

Ca+Cg

31.0 ±13.2

49.4 ±14.7

0.318

p-value

0.456a

0.021a
Ca+Cg vs. Ca+Sm: p = 0.042b
Cg+Sm vs. Ca+Cg: p = 0.021b

* statistically significant (p < 0.05, MANOVA); a MANOVA; b Tukey’s post hoc test; Ca – Candida albicans; Sm – Streptococcus mutans; Cg – Candida glabrata.

Figures


Fig. 1. Methodology of Er:YAG (erbium-doped yttrium aluminum garnet) laser irradiation of planktonic solutions of cells and biofilm

References (62)

  1. Kapila YL. Oral health’s inextricable connection to systemic health: Special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontol 2000. 2021;87(1):11–16. doi:10.1111/prd.12398
  2. Graves DT, Corrêa JD, Silva TA. The oral microbiota is modified by systemic diseases. J Dent Res. 2019;98(2):148–156. doi:10.1177/0022034518805739
  3. Hu Q, Wang S, Zhang W, Qu J, Liu GH. Unraveling brain aging through the lens of oral microbiota. Neural Regen Res. 2025;20(7):1930–1943. doi:10.4103/NRR.NRR-D-23-01761
  4. Slowik J, Wnuk MA, Grzech K, et al. Periodontitis affects neurological deficit in acute stroke. J Neurol Sci. 2010;297(1–2):82–84. doi:10.1016/j.jns.2010.07.012
  5. Nomura R, Matayoshi S, Otsugu M, Kitamura T, Teramoto N, Nakano K. Contribution of severe dental caries induced by Streptococcus mutans to the pathogenicity of infective endocarditis. Infect Immun. 2020;88(7):e00897–e00919. doi:10.1128/IAI.00897-19
  6. Fumes AC, da Silva Telles PD, Corona SAM, Borsatto MC. Effect of aPDT on Streptococcus mutans and Candida albicans present in the dental biofilm: Systematic review. Photodiagnosis Photodyn Ther. 2018;21:363–366. doi:10.1016/j.pdpdt.2018.01.013
  7. Girois SB, Chapuis F, Decullier E, Revol BGP. Adverse effects of antifungal therapies in invasive fungal infections: Review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2005;24(2):119–130. doi:10.1007/s10096-005-1281-2
  8. Contaldo M, Di Stasio D, Romano A, et al. Oral candidiasis and novel therapeutic strategies: Antifungals, phytotherapy, probiotics, and photodynamic therapy. Curr Drug Deliv. 2023;20(5):441–456. doi:10.2174/1567201819666220418104042
  9. Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. Br Dent J. 2017;223(9):675–681. doi:10.1038/sj.bdj.2017.886
  10. Millsop JW, Fazel N. Oral candidiasis. Clin Dermatol. 2016;34(4):487–494. doi:10.1016/j.clindermatol.2016.02.022
  11. Shenoy A, Gottlieb A. Probiotics for oral and vulvovaginal candidiasis: A review. Dermatol Ther. 2019;32(4):e12970. doi:10.1111/dth.12970
  12. Russo R, Superti F, Karadja E, De Seta F. Randomised clinical trial in women with recurrent vulvovaginal candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses. 2019;62(4):328–335. doi:10.1111/myc.12883
  13. Matys J, Grzech-Leśniak K, Flieger R, Dominiak M. Assessment of an impact of a diode laser mode with wavelength of 980 nm on a temperature rise measured by means of k-02 thermocouple: Preliminary results. Dent Med Probl. 2016;53(3):345–351. doi:10.17219/dmp/62575
  14. Grzech-Leśniak K. Making use of lasers in periodontal treatment: A new gold standard? Photomed Laser Surg. 2017;35(10):513–514. doi:10.1089/pho.2017.4323
  15. Wiench R, Skaba D, Matys J, Grzech-Leśniak K. Efficacy of toluidine blue-mediated antimicrobial photodynamic therapy on Candida spp. A systematic review. Antibiotics (Basel). 2021;10(4):349. doi:10.3390/antibiotics10040349
  16. Wiench R, Nowicka J, Pajączkowska M, et al. Influence of incubation time on ortho-toluidine blue mediated antimicrobial photodynamic therapy directed against selected Candida strains – an in vitro study. Int J Mol Sci. 2021;22(20):10971. doi:10.3390/ijms222010971
  17. Nammour S, El Mobadder M, Namour M, et al. Aesthetic treatment outcomes of capillary hemangioma, venous lake, and venous malformation of the lip using different surgical procedures and laser wavelengths (Nd:YAG, Er,Cr:YSGG, CO2, and diode 980 nm). Int J Environ Res Public Health. 2020;17(22):8665. doi:10.3390/ijerph17228665
  18. Elkharashi A, Grzech-Leśniak K, Deeb JG, Abdulmajeed AA, Bencharit S. Exploring the use of pulsed erbium lasers to retrieve a zirconia crown from a zirconia implant abutment. PLoS One. 2020;15(6):e0233536. doi:10.1371/journal.pone.0233536
  19. El Mobadder M, Nammour S, Namour M, Namour A, Grzech-Leśniak K. Disinfection potential of 980 nm diode laser and hydrogen peroxide (3%) in “critical probing depths” periodontal pockets: Retrospective study. Life (Basel). 2022;12(3):370. doi:10.3390/life12030370
  20. Arnabat-Dominguez J, Del Vecchio A, Todea C, et al. Laser dentistry in daily practice during the COVID-19 pandemic: Benefits, risks and recommendations for safe treatments. Adv Clin Exp Med. 2021;30(2):119–125. doi:10.17219/acem/130598
  21. Grzech-Leśniak K, Belvin BR, Lewis JP, Golob Deeb J. Treatment with Nd:YAG laser irradiation combined with sodium hypochlorite or hydrogen peroxide irrigation on periodontal pathogens: An in vitro study. Photobiomodul Photomed Laser Surg. 2021;39(1):46–52. doi:10.1089/photob.2019.4775
  22. Grzech-Leśniak K, Nowicka J, Pajączkowska M, et al. Effects of Nd:YAG laser irradiation on the growth of Candida albicans and Streptococcus mutans: In vitro study. Lasers Med Sci. 2019;34(1):129–137. doi:10.1007/s10103-018-2622-6
  23. Grzech-Leśniak Z, Szwach J, Lelonkiewicz M, et al. Effect of Nd:YAG laser irradiation on the growth of oral biofilm. Microorganisms. 2024;12(11):2231. doi:10.3390/microorganisms12112231
  24. El Mobadder M, Nammour S, Grzech-Leśniak Z, Grzech-Leśniak K. Efficacy of the adjunct use of povidone-iodine or sodium hypochlorite with non-surgical management of periodontitis: A systematic review and meta-analysis. J Clin Med. 2022;11(21):6593. doi:10.3390/jcm11216593
  25. Sterczała B, Grzech-Leśniak K, Michel O, Trzeciakowski W, Dominiak M, Jurczyszyn K. Assessment of human gingival fibroblast proliferation after laser stimulation in vitro using different laser types and wavelengths (1064, 980, 635, 450, and 405 nm) – preliminary report. J Pers Med. 2021;11(2):98. doi:10.3390/jpm11020098
  26. Golob Deeb J, Reddy N, Kitten T, Carrico CK, Grzech-Leśniak K. Viability of bacteria associated with root caries after Nd:YAG laser application in combination with various antimicrobial agents: An in vitro study. Dent Med Probl. 2023;60(4):649–655. doi:10.17219/dmp/171690
  27. Pion LA, Machado De Matos LL, Gimenez T, Palma-Dibb RG, Faraoni JJ. Treatment outcome for dentin hypersensitivity with laser therapy: Systematic review and meta-analysis. Dent Med Probl. 2023;60(1):153–166. doi:10.17219/dmp/151482
  28. Torres-Rosas R, Torres-Gómez N, Camero-Leal JA, Jurado C, López-Ravelo H, Argueta-Figueroa L. Force decay and elongation of orthodontic elastomeric chains exposed to different beverages common in the diet: An in vitro study. Dent Med Probl. 2023;60(3):413–420. doi:10.17219/dmp/148052
  29. Mosaddad SA, Mahootchi P, Rastegar Z, et al. Photodynamic therapy in oral cancer: A narrative review. Photobiomodul Photomed Laser Surg. 2023;41(6):248–264. doi:10.1089/photob.2023.0030
  30. Uzeda MJ, Silva AM, Costa LN, Brito FS, Fernandes GV, Resende RF. Evaluating the effectiveness of low-level laser therapy in patients undergoing lower third molar extraction: A double-blinded randomized controlled trial. Med Oral Patol Oral Cir Bucal. 2025;30(1):e129–e134. doi:10.4317/medoral.26894
  31. Golob Deeb J, Grzech-Lesniak K, Bencharit S. Evaluation of the effectiveness and practicality of erbium lasers for ceramic restoration removal: A retrospective clinical analysis. PLoS One. 2023;18(12):e0295957. doi:10.1371/journal.pone.0295957
  32. Golob Deeb J, Grzech-Leśniak K, Brody ER, Matys J, Bencharit S. Erbium laser-assisted ceramic debonding: A scoping review. J Prosthodont. 2022;31(9):e100–e124. doi:10.1111/jopr.13613
  33. Grzech-Leśniak K, Matys J. The effect of Er:YAG lasers on the reduction of aerosol formation for dental workers. Materials (Basel). 2021;14(11):2857. doi:10.3390/ma14112857
  34. Golob Deeb J, Skrjanc L, Kanduti D, Carrico C, Saturno AM, Grzech-Leśniak K. Evaluation of Er:YAG and Er,Cr:YSGG laser irradiation for the debonding of prefabricated zirconia crowns. Adv Clin Exp Med. 2021;30(1):7–15. doi:10.17219/acem/127686
  35. Golob Deeb J, Grzech-Leśniak K, Weaver C, Matys J, Bencharit S. Retrieval of glass fiber post using Er:YAG laser and conventional endodontic ultrasonic method: An in vitro study. J Prosthodont. 2019;28(9):1024–1028. doi:10.1111/jopr.13114
  36. Grzech-Leśniak K, Bencharit S, Dalal N, Mroczka K, Golob Deeb J. In vitro examination of the use of Er:YAG laser to retrieve lithium disilicate crowns from titanium implant abutments. J Prosthodont. 2019;28(6):672–676. doi:10.1111/jopr.13077
  37. Rubio F, Arnabat-Domínguez J, Sans-Serramitjana E, Saa C, Grzech-Leśniak K, Betancourt P. Antimicrobial photodynamic therapy combined with photobiomodulation therapy in teeth with asymptomatic apical periodontitis: A case series. Appl Sci. 2024;14(20):9341. doi:10.3390/app14209341
  38. Nagahashi T, Yahata Y, Handa K, et al. Er:YAG laser-induced cavitation can activate irrigation for the removal of intraradicular biofilm. Sci Rep. 2022;12(1):4897. doi:10.1038/s41598-022-08963-x
  39. Nammour S, El Mobadder M, Namour M, et al. Success rate of direct pulp capping with conventional procedures using Ca (OH)2 and bioactive tricalcium silicate paste vs. laser-assisted procedures (diode 980 nm, CO2, and Er: YAG). Photonics. 2023;10(7):834. doi:10.3390/photonics10070834
  40. AlMoharib HS, Steffensen B, Zoukhri D, Finkelman M, Gyurko R. Efficacy of an Er:YAG laser in the decontamination of dental implant surfaces: An in vitro study. J Periodontol. 2021;92(11):1613–1621. doi:10.1002/JPER.20-0765
  41. Vezzani MS, Pietro R, Silva-Sousa YT, Brugnera-Junior A, Sousa-Neto MD. Disinfection of root canals using Er:YAG laser at different frequencies. Photomed Laser Surg. 2006;24(4):499–502. doi:10.1089/pho.2006.24.499
  42. Świder K, Dominiak M, Grzech-Leśniak K, Matys J. Effect of different laser wavelengths on periodontopathogens in peri-implantitis: A review of in vivo studies. Microorganisms. 2019;7(7):189. doi:10.3390/microorganisms7070189
  43. Matys J, Świder K, Grzech-Leśniak K, Dominiak M, Romeo U. Photobiomodulation by a 635nm diode laser on peri-implant bone: Primary and secondary stability and bone density analysis – a randomized clinical trial. Biomed Res Int. 2019;2019:2785302. doi:10.1155/2019/2785302
  44. Hou X, Yuan K, Huang Z, Ma R. Effects of bleaching associated with Er:YAG and Nd:YAG laser on enamel structure and bacterial biofilm formation. Scanning. 2021;2021:6400605. doi:10.1155/2021/6400605
  45. Grzech-Leśniak K, Matys J, Jurczyszyn K, et al. Histological and thermometric examination of soft tissue de-epithelialization using digitally controlled Er:YAG laser handpiece: An ex vivo study. Photomed Laser Surg. 2018;36(6):313–319. doi:10.1089/pho.2017.4413
  46. Grzech-Leśniak K, Matys J, Dominiak M. Comparison of the clinical and microbiological effects of antibiotic therapy in periodontal pockets following laser treatment: An in vivo study. Adv Clin Exp Med. 2018;27(9):1263–1270. doi:10.17219/acem/70413
  47. Golob Deeb J, Smith J, Ross Belvin B, Lewis J, Grzech-Leśniak K. Er:YAG laser irradiation reduces microbial viability when used in combination with irrigation with sodium hypochlorite, chlorhexidine, and hydrogen peroxide. Microorganisms. 2019;7(12):612. doi:10.3390/microorganisms7120612
  48. Sennhenn-Kirchner S, Schwarz P, Schliephake H, Konietschke F, Brunner E, Borg-von Zepelin M. Decontamination efficacy of erbium:yttrium-aluminium-garnet and diode laser light on oral Candida albicans isolates of a 5-day in vitro biofilm model. Lasers Med Sci. 2009;24(3):313–320. doi:10.1007/s10103-008-0561-3
  49. El Mobadder M, Nammour S, Matys J, Grzech-Leśniak K. Sodium hypochlorite and diode laser in non-surgical treatment of periodontitis: Clinical and bacteriological study with real time polymerase chain reaction (PCR). Life (Basel). 2022;12(10):1637. doi:10.3390/life12101637
  50. Reddy N, Golob Deeb J, Kitten T, Carrico CK, Grzech-Leśniak K. The in vitro effect of laser irradiation (Er:YAG and CO2) and chemical reagents (hydrogen peroxide, sodium hypochlorite, chlorhexidine, or sodium fluoride) alone or in combination on reducing root caries bacteria. Int J Mol Sci. 2022;23(24):15732. doi:10.3390/ijms232415732
  51. Henninger E, Berto LA, Eick S, Lussi A, Neuhaus KW. In vitro effect of Er:YAG laser on different single and mixed microorganisms being associated with endodontic infections. Photobiomodul Photomed Laser Surg. 2019;37(6):369–375. doi:10.1089/photob.2018.4557
  52. Bordea IR, Hanna R, Chiniforush N, et al. Evaluation of the outcome of various laser therapy applications in root canal disinfection: A systematic review. Photodiagnosis Photodyn Ther. 2020;29:101611. doi:10.1016/j.pdpdt.2019.101611
  53. Polak D, Shani-Kdoshim S, Alias M, Shapira L, Stabholz A. The in vitro efficacy of biofilm removal from titanium surfaces using Er:YAG laser: Comparison of treatment protocols and ablation parameters. J Periodontol. 2022;93(1):100–109. doi:10.1002/JPER.19-0574
  54. Liddell LT, Rosen T. Laser therapy for onychomycosis: Fact or fiction? J Fungi (Basel). 2015;1(1):44–54. doi:10.3390/jof1010044
  55. Salehi B, Kregiel D, Mahady G, Sharifi-Rad J, Martins N, Rodrigues CF. Management of Streptococcus mutans-Candida spp. oral biofilms’ infections: Paving the way for effective clinical interventions. J Clin Med. 2020;9(2):517. doi:10.3390/jcm9020517
  56. Misischia WP, Xenoudi P, Yukna RA, Schurr MJ. Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro. Lasers Med Sci. 2021;36(8):1759–1767. doi:10.1007/s10103-021-03349-3
  57. Wang X, Yuan C, Wo Y, et al. Will repeated ablative Er:YAG laser treatment sessions cause facial skin sensitivity? Results of a 12-month, prospective, randomized split-face study. Rejuvenation Res. 2020;23(2):122–129. doi:10.1089/rej.2018.2168
  58. Medved F, Wurm A, Held M. Facial microcirculatory and biomechanical skin properties after single high energy (Er):YAG laser application. Lasers Surg Med. 2017;49(10):891–898. doi:10.1002/lsm.22710
  59. Holcomb JD. Versatility of erbium YAG laser: From fractional skin rejuvenation to full-field skin resurfacing. Facial Plast Surg Clin North Am. 2011;19(2):261–273. doi:10.1016/j.fsc.2011.04.005
  60. Frelich H, Marków M, Tażbirek M, Frelich-Truchel H, Misiołek M, Ścierski W. Erbium:yttrium aluminum garnet (Er:YAG) laser: A minimally invasive treatment method in selected patients with impaired breathing during sleep – the assessment of treatment effectiveness after 4 years. Photobiomodul Photomed Laser Surg. 2023;41(8):415–421. doi:10.1089/photob.2022.0144
  61. Storchi IF, Parker S, Bovis F, Benedicenti S, Amaroli A. Outpatient erbium:YAG (2940 nm) laser treatment for snoring: A prospective study on 40 patients. Lasers Med Sci. 2018;33(2):399–406. doi:10.1007/s10103-018-2436-6
  62. Fernandes GVO, Alves GG, Linhares ABR, Prado da Silva MH, Granjeiro JM. Evaluation of cytocompatibility of bioglass-niobium granules with human primary osteoblasts: A multiparametric approach. Key Eng Mater. 2011;493–494:37–42. doi:10.4028/www.scientific.net/kem.493-494.37